Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries Publisher Pubmed



Nemati S1 ; Saeedi E1, 2 ; Lotfi F1 ; Nahvijou A1 ; Mohebbi E1 ; Ravankhah Z3 ; Rezaeianzadeh A4 ; Yaghoobiashrafi M5 ; Pirnejad H6 ; Golpazir A7 ; Dolatkhah R8 ; Alvand S9 ; Ahmaditabatabaei SV10 ; Cheraghi M11 Show All Authors
Authors
  1. Nemati S1
  2. Saeedi E1, 2
  3. Lotfi F1
  4. Nahvijou A1
  5. Mohebbi E1
  6. Ravankhah Z3
  7. Rezaeianzadeh A4
  8. Yaghoobiashrafi M5
  9. Pirnejad H6
  10. Golpazir A7
  11. Dolatkhah R8
  12. Alvand S9
  13. Ahmaditabatabaei SV10
  14. Cheraghi M11
  15. Weiderpass E12
  16. Bray F12
  17. Coleman MP13
  18. Etemadi A14
  19. Khosravi A15
  20. Najafi F16
  21. Mohagheghi MA1
  22. Roshandel G17
  23. Malekzadeh R18
  24. Zendehdel K1
Show Affiliations
Authors Affiliations
  1. 1. Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Biostatistics Research Group, Department of Health Science, University of Leicester, Leicester, United Kingdom
  3. 3. Esfahan Cancer Registry, Esfahan University of Medical Sciences, Esfahan, Iran
  4. 4. Shiraz Cancer Registry, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Mazandaran Cancer Registry, Mazandaran University of Medical Sciences, Sari, Iran
  6. 6. Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
  7. 7. Kermanshah Cancer Registry, Kermanshah University of Medical Sciences, Kermanshah, Iran
  8. 8. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  9. 9. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Kerman Cancer Registry, Kerman University of Medical Sciences, Kerman, Iran
  11. 11. Cancer Registry Section, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  12. 12. International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France
  13. 13. Cancer Survival Group, Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
  14. 14. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
  15. 15. Deputy of Health, Ministry of Health and Medical Education, Tehran, Iran
  16. 16. Department of Epidemiology and Biostatistics, Kermanshah University of Medical Sciences, Kermanshah, Iran
  17. 17. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
  18. 18. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Cancer Published:2022


Abstract

Cancer survival is a key indicator for the national cancer control programs. However, survival data in the East Mediterranean region (EMR) are limited. We designed a national cancer survival study based on population-based cancer registries (PBCRs) from nine provinces in Iran. The current study reports 5-year net survival of 15 cancers in Iranian adults (15-99 years) during 2014 to 2015 in nine provinces of Iran. We used data linkages between the cancer registries and the causes of death registry and vital statistics and active follow-up approaches to ascertain the vital status of the patients. Five-year net survival was estimated through the relative survival analysis. We applied the international cancer survival standard weights for age standardization. Five-year survival was highest for prostate cancer (74.9%, 95% CI 73.0, 76.8), followed by breast (74.4%, 95% CI 72.50, 76.3), bladder (70.4%, 95% CI 69.0, 71.8) and cervix (65.2%, 95% CI 60.5, 69.6). Survival was below 25% for cancers of the pancreas, lung, liver, stomach and esophagus. Iranian cancer patients experience a relatively poor prognosis as compared to those in high-income countries. Implementation of early detection programs and improving the quality of care are required to improve the cancer survival among Iranian patients. Further studies are needed to monitor the outcomes of cancer patients in Iran and other EMR countries. © 2022 UICC.
Related Docs
View other Related Docs
1. Regional Disparities in Cancer Survival in Iran: Insight From a National Surveillance of Cancer Survival in Iran (Irancansurv), Cancer Epidemiology (2023)
2. Incidence of Colorectal Cancer in Iran: A Systematic Review and Meta‑Analysis, Journal of Research in Medical Sciences (2024)
3. Cancer Incidence in Iran in 2014: Results of the Iranian National Population-Based Cancer Registry, Cancer Epidemiology (2019)
4. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)
5. Cancer Epidemiology and Trends in Sistan and Baluchestan Province, Iran, Medical Journal of the Islamic Republic of Iran (2015)
6. Survival of Patients With Lung Cancer, Yazd, Iran, Asian Pacific Journal of Cancer Prevention (2012)
7. Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015, International Journal of Preventive Medicine (2012)
8. A Study of the Long-Term Trend of Epidemiological and Clinical Indices of Breast Cancer in Isfahan, Journal of Isfahan Medical School (2012)
Experts (# of related papers)
View all Related Experts
Zahra Tolou-Ghamari (7)
Ali Akhavan (4)
Other Related Docs
9. The Most Common Cancers in Iranian Women, Iranian Journal of Public Health (2009)
10. Preliminary Study of Prevalence for Bladder Cancer in Isfahan Province, Iran, Arab Journal of Urology (2018)
11. Relations of Disease-Free Survival and Overall Survival With Age and Primary Metastases in Patients With Breast Cancer, Journal of Isfahan Medical School (2013)
12. Incidence, Prevalence, and Mortality Rate of Gastrointestinal Cancer in Isfahan, Iran: Application of the Miamod Method, Asian Pacific Journal of Cancer Prevention (2016)
13. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
14. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
15. The Risk Factors of Prostate Cancer: A Multicentric Case-Control Study in Iran, Asian Pacific Journal of Cancer Prevention (2007)
16. Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis, Asian Pacific Journal of Cancer Prevention (2019)
17. Cancer in Iran 2008 to 2025: Recent Incidence Trends and Short-Term Predictions of the Future Burden, International Journal of Cancer (2021)
18. Rational, Design and Preliminary Results of a Cohort Study on Breast and Colorectal Cancer to Develop a Risk Assessment Model to Predict Future Cardiovascular Events. “Cardio Vascular Events in Breast and Colorectal Cancers (Cibc) Study”, Current Problems in Cardiology (2022)
19. Application of Multi-State Model in Analyzing of Breast Cancer Data, Journal of Research in Health Sciences (2019)
20. Survival Analysis of Iranian Patients With Breast Cancer Using Joint Frailty Model With a Cure Rate, Middle East Journal of Cancer (2021)
21. Predictors of Survival Rate in Patients With Pancreatic Cancer: A Multi-Center Analytical Study in Iran, Cancer Reports (2022)
22. Geographic Distribution of Cancer Cases in Isfahan Province/2006–2010, International Journal of Preventive Medicine (2015)
23. Results of Combination Chemotherapy and Radiation Therapy in Non-Metastatic Gastric Cancer in Yazd - Iran, Indian Journal of Cancer (2015)
24. Perception of Iranian Patients With Cancer, Their Relatives, and Health Care Professionals Towards Length of Life and Quality of Life: A Local Survey, Shiraz E Medical Journal (2021)
25. One-Year Survival and Prognostic Factors for Survival Among Stroke Patients: The Prove-Stroke Study, Journal of Research in Medical Sciences (2022)
26. The Epidemiology of Skin Cancer and Its Trend in Iran, International Journal of Preventive Medicine (2015)
27. The Incidence and Mortality of Prostate Cancer and Its Relationship With Development in Asia, Prostate International (2015)
28. Prevalence of Lung Cancer in Isfahan Province, Iran, Journal of the Egyptian National Cancer Institute (2018)
29. Prognostic Factors and Outcome of Patients With Adult Acute Lymphoblastic Leukemia Treated With the Hyper-Cvad Regimen: A Retrospective Study, Advances in Hematology (2023)
30. Psycho-Oncology Curriculum Needs Assessment in Postgraduate Education, International Journal of Body, Mind and Culture (2020)
31. Spatio-Temporal Pattern of Two Common Cancers Among Iranian Women: An Adaptive Smoothing Model, Journal of B.U.ON. (2019)
32. A Comparative Study on Cancer Prevention Principles Between Iranian Traditional Medicine and Classic Medicine, International Journal of Preventive Medicine (2016)
33. The Economic Cost of Cancer Treatment in Iran, Journal of Education and Health Promotion (2023)
34. Death Portrait of Isfahan Province in Years 2007-2011, International Journal of Preventive Medicine (2016)
35. Cost Evaluation of Chemotherapy and Epidemiology of Five Most Common Cancers in Isfahan Province in Iran, Tehran University Medical Journal (2020)
36. Prevalence of Stomach Cancer in Isfahan Province, Iran, The Gulf journal of oncology (2018)
37. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2023)
38. Outcome Evaluation of Patients With Acute Lymphocytic Leukemia Treated by Hyper-Cvad Chemotherapy Regimen: A Brief Report, Tehran University Medical Journal (2023)
39. Temporal Trends of Incidence of Colorectal Cancer in Isfahan, Iran, 2000-2011, International Journal of Preventive Medicine (2018)
40. The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-Stage Breast Cancer Patients, International Journal of Preventive Medicine (2015)
41. Multiple Associations of Clinicopathological Characteristics and Risk Factors of Colorectal Cancer in the Iranian Population, Middle East Journal of Cancer (2021)
42. Incidence and Mortality of Breast Cancer and Their Relationship to Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
43. Bivariate Spatiotemporal Disease Mapping of Cancer of the Breast and Cervix Uteri Among Iranian Women, Geospatial Health (2018)
44. Clinical Breast Cancer Registry of Ir. Iran (Cbcr-Ir): Study Protocol and First Results, Archives of Iranian Medicine (2023)
45. Investigating the Incidence of Prostate Cancer in Iran 2005-2008 Using Bayesian Spatial Ecological Regression Models, Asian Pacific Journal of Cancer Prevention (2015)
46. The Relation Between Tumor Lengths and Survival in Patients With Esophageal Cancer, Journal of Isfahan Medical School (2020)
47. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
48. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
49. The Incidence and Mortality of Ovarian Cancer and Their Relationship With the Human Development Index in Asia, ecancermedicalscience (2016)
50. Survival Rate of Patients Suffering From Gastric Adenocarcinoma of Yazd City, Trauma Monthly (2011)